SCD and gastric cancer: Exo-lncFERO derived from GC cells then enters gastric cancer stem cells (GCSCs) and upregulates SCD1 expression in GCSCs by binding SCD1-associated mRNA and recruiting hnRNPA1, thereby suppressing GCSC ferroptosis and reducing chemosensitivity in GC cells.